Af­ter bail­ing on Covid-19 vac­cines, Mer­ck will team up with J&J to pro­duce its shot as part of un­usu­al Big Phar­ma pact

Mer­ck took a big gam­ble when it opt­ed to jump in­to the Covid-19 vac­cine race late, and made an equal­ly mo­men­tous de­ci­sion to back out in late Jan­u­ary. Now, look­ing to chip in on the ef­fort, Mer­ck re­port­ed­ly agreed to team up with one of the com­pa­nies that has al­ready crossed the fin­ish line.

Pres­i­dent Joe Biden on Tues­day is ex­pect­ed to an­nounce a part­ner­ship be­tween drug­mak­ers Mer­ck and John­son & John­son to joint­ly pro­duce J&J’s re­com­bi­nant vi­ral vec­tor Covid-19 vac­cine that re­ceived the FDA’s emer­gency use au­tho­riza­tion Sat­ur­day, the Wash­ing­ton Post re­port­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.